← All organizations
Highest phase reached
Phase 3
First clinical trial
May 1, 2015Last known activity
Sep 30, 2020
Acquired by The EMMES Corporation on May 12, 2021
Timeline
2000s
- Jun 1, 2004
Orphan Reach— Founded
2020s
- May 12, 2021
The EMMES Corporation— Acquired By
Drugs by trial phase (2 distinct, 3 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Recent trials (3)
- NCT04533022CollaboratorPhase 2Sep 30, 2020
- NCT04452435CollaboratorPhase 2Jul 21, 2020
- NCT02452931Study directorPhase 3May 1, 2015
Details
- Founded
- Milton Keynes, GB Jun 1, 2004
- Last known activity
- Sep 30, 2020
Notes
CRO